| ○ |
|
葛原 茂樹 |
鈴鹿医療科学大学保健衛生学部医療福祉学科教授 |
| 神経変性疾患、痴呆性疾患、医原性神経疾患、脳血管障害 |
Ishiura H, Takahashi Y, Mitsui J, Yoshida S, Kihira T, Kokubo Y, Kuzuhara S, Ranum LP, Tamaoki T, Ichikawa Y, Date H, Goto J, Tsuji S.
C9ORF72 Repeat Expansion in Amyotrophic Lateral Sclerosis in the Kii Peninsula of JapanC9ORF72 Repeat Expansion in ALS. Arch Neurol. 2012 Jun 4:1-5.
|
| Kokubo Y, Taniguchi A, Hasegawa M, Hayakawa Y, Morimoto S, Yoneda M, Hirokawa Y, Shiraishi T, Saito Y, Murayama S, Kuzuhara S. α-Synuclein pathology in the amyotrophic lateral sclerosis/parkinsonism dementia complex in the Kii Peninsula, Japan.J Neuropathol Exp Neurol. 2012 Jul;71(7):625-30. |
| Kuzuhara S, Kokubo Y, Sasaki R, Narita Y, Yabana T, Hasegawa M, Iwatsubo T: Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 49:501-511, 2001 |
|
| |
|
篠原 幸人 |
国家公務員共済組合連合会立川病院 院長 |
| 神経内科学 |
Shinohara Y: Hemorrhagic stroke syndrome: Clinical manifestation of intracerebral and subarachnoid hemorrhage.
In “Handbook of Clinical Neurology, Vol. 93, Chap 28”, ed by Mark Fisher.
Elsevier, Edinburgh. pp577-594, 2009
|
Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tushima M, Koretsune Y, Sawada T, Hamada C, for the CSPS 2 group: Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Lancet Neurol 9: 959-968, 2010
|
Shinohara Y, Goto S, Doi M, Jensen P: Safety of the novel protease-activated receptor-1 antagonist vorapaxar in Japanese patients with a history of ischemic stroke.
J Stroke Cerebrovasc Dis 21: 318-324, 2012
|
|
| |
|
高守 正治 |
金沢西病院脳神経センター長 金沢大学名誉教授 |
| 神経免疫学、神経生理学 |
| Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. Takamori M. J Neuroimmunol. 2008 Sept; 201-202: 145-152. |
| Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis. Takamori M. J Neuroimmunol. 2008 Aug; 200(1-2): 142-144. |
| Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Takamori M, Motomura M, Fukudome T, Yoshikawa H. Eur J Neurol 2007 Nov; 14(11): 1230-1235. |
|
| |
|
田村 晃 |
富士脳障害研究所附属病院院長 |
| 脳神経外科 |
| Kuroiwa T, Miyasaka N, Fengyo Z, Yamada I, Nakane M, Nagaoka T, Tamura A, Ohno K: Experimental ischemic brain edema: morphological and magnetic resonance imaging findings. Neurosurg Focus 2007;22(5):E11(1-8) |
| Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35(6):1364-1367 |
| Nakatomi H, Kuriu T. Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M: Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002; 110:429-441 |
|
| |
|
西澤 正豊 |
新潟大学脳研究所神経内科学分野教授 |
| 神経内科学 |
| Yanagawa K, Kawachi I, Yokoseki A, Arakawa M, Hasegawa A, Ito Y, Kojima N, Koike R, Tanaka K, Kosaka T, Tan C-F, Toyoshima Y, Kakita A, Tsujita M, Sakimura K, Takahashi H, Nishizawa M: Clinical course and pathological characterization of a limited form of neuromyelitis optica with myelitis: homogeneity of pathogenesis and heterogeneity of treatment response through long-term courses of neuromyelitis optica. Neurology 2009; 73 (20): 1628-1637. PMID: 19917985 |
| Kanazawa M, Shimohata T, Toyoshima Y, Tada M, Kakita A, Morita T, Ozawa T, Takahashi H, Nishizawa M: Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 2009; 24 (9): 1312-1318. PMID: 19412943 |
| Shimohata T, Shinoda H, Nakayama H, Ozawa T, Terajima K, Yoshizawa H, Matsuzawa Y, Onodera O, Naruse S, Tanaka K, Takahashi S, Gejyo F, Nishizawa M.: Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol 2007; 64 (6): 856-861, PMID: 17562934 |
|
| |
|
御子柴 克彦 |
理化学研究所グループディレクター |
| 脳神経科学 |
Futatsugi, A., Nakamura, T., Yamada, M. K.,Ebisui, E., Nakamura, K., Uchida, K., Kitaguchi, T., Takahashi-Iwanaga, H., Noda, T., Aruga, J. & Mikoshiba, K.: IP3 Receptor Types 2 and 3 mediate exocrine secretion underlying energy metabolism Science 309: 2232-2234 (2005)
|
| Higo, T., Hattori, M., Nakamura, T., Natsume, T., Michikawa, T & Mikoshiba,K.:Subtype-specific and ER-lumenal-environment-dependent Regulation of Inositol 1,4,5-Trisphosphate Receptor Type 1 by ERp44. Cell 120: 85-98 (2005) |
| Higo T, Hamada K, Hisatsune C, Nukina N, Hashikawa T, Hattori M, Nakamura T, Mikoshiba K. Mechanism of ER stress-induced brain damage by IP3 receptor. Neuron 68(5): 865-878 (2010) |
|
